Published in Tissue Eng on March 01, 2006
Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev (2012) 1.07
Gene therapy for bone healing. Expert Rev Mol Med (2010) 1.02
Engineering extracellular matrix through nanotechnology. J R Soc Interface (2010) 1.00
Orthopedic gene therapy in 2008. Mol Ther (2008) 0.98
Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. Tissue Eng Part B Rev (2010) 0.95
Gene delivery to bone. Adv Drug Deliv Rev (2012) 0.93
Localized SDF-1alpha gene release mediated by collagen substrate induces CD117 stem cells homing. J Cell Mol Med (2008) 0.84
Gene delivery by surface immobilization of plasmid to tissue-engineering scaffolds. Gene Ther (2010) 0.83
Characterization and evaluation of the efficacy of cationic complex mediated plasmid DNA delivery in human embryonic palatal mesenchyme cells. J Tissue Eng Regen Med (2014) 0.83
An ectopic study of apatite-coated silk fibroin scaffolds seeded with AdBMP-2-modified canine bMSCs. J Biomater Sci Polym Ed (2011) 0.80
Non-viral gene-activated matrices: next generation constructs for bone repair. Organogenesis (2013) 0.79
Cell-based gene therapy for repair of critical size defects in the rat fibula. J Cell Biochem (2011) 0.79
Gene therapy: implications for craniofacial regeneration. J Craniofac Surg (2012) 0.77
Bone Regeneration Using Gene-Activated Matrices. AAPS J (2016) 0.75
Regeneration of bone- and tendon/ligament-like tissues induced by gene transfer of bone morphogenetic protein-12 in a rat bone defect. J Tissue Eng (2010) 0.75
Gene-Activated Matrix Comprised of Atelocollagen and Plasmid DNA Encoding BMP4 or Runx2 Promotes Rat Cranial Bone Augmentation. Biores Open Access (2015) 0.75
Design of novel 3D gene activated PEG scaffolds with ordered pore structure. J Mater Sci Mater Med (2010) 0.75
Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science (2008) 3.38
Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med (2004) 2.94
A comparative study of cone-beam computed tomography and conventional panoramic radiography in assessing the topographic relationship between the mandibular canal and impacted third molars. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 2.22
Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med (2006) 1.93
The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD). Am J Hum Genet (2004) 1.86
Fully functional bioengineered tooth replacement as an organ replacement therapy. Proc Natl Acad Sci U S A (2009) 1.82
IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature (2010) 1.76
A simple biological imaging system for detecting viable human circulating tumor cells. J Clin Invest (2009) 1.36
A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases. Clin Cancer Res (2013) 1.29
Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis. Am J Physiol Gastrointest Liver Physiol (2009) 1.27
The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C. Dev Cell (2002) 1.24
Expression of dentin matrix protein 1 (DMP1) in nonmineralized tissues. J Bone Miner Metab (2004) 1.22
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. J Bone Miner Res (2004) 1.19
Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci (2008) 1.18
Functional tooth regeneration using a bioengineered tooth unit as a mature organ replacement regenerative therapy. PLoS One (2011) 1.17
A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. J Clin Invest (2006) 1.15
The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. J Bone Miner Res (2010) 1.09
Effects of mechanical strain on proliferation and differentiation of bone marrow stromal cell line ST2. J Bone Miner Metab (2005) 1.06
Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody. Biochem Biophys Res Commun (2006) 1.03
EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. PLoS One (2011) 1.02
A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis. Arthritis Rheum (2007) 1.01
Bone formation with the combination of simvastatin and calcium sulfate in critical-sized rat calvarial defect. J Pharmacol Sci (2007) 0.99
Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice. Endocrinology (2010) 0.98
Autosomal dominant gnathodiaphyseal dysplasia maps to chromosome 11p14.3-15.1. J Bone Miner Res (2003) 0.97
Impact of the Static and Radiofrequency Magnetic Fields Produced by a 7T MR Imager on Metallic Dental Materials. Magn Reson Med Sci (2015) 0.94
Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis. Int J Cancer (2012) 0.94
Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity. J Biol Chem (2013) 0.94
Localization and inhibitory effect of basic fibroblast growth factor on chondrogenesis in cultured mouse mandibular condyle. J Bone Miner Metab (2003) 0.94
Molecular and cell biological properties of mouse osteogenic mesenchymal progenitor cells, Kusa. J Bone Miner Metab (2005) 0.94
Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation. J Bone Miner Res (2010) 0.93
Molecular and tissue responses in the healing of rat calvarial defects after local application of simvastatin combined with alpha tricalcium phosphate. J Biomed Mater Res B Appl Biomater (2010) 0.92
Total Syntheses of (-)-Mesembrane and (-)-Mesembrine via Palladium-Catalyzed Enantioselective Allylic Substitution and Zirconium-Promoted Cyclization. J Org Chem (1997) 0.91
Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts. J Biol Chem (2010) 0.91
The effects of enamel matrix derivative (EMD) on osteoblastic cells in culture and bone regeneration in a rat skull defect. J Periodontal Res (2003) 0.90
S100A4: a novel negative regulator of mineralization and osteoblast differentiation. J Bone Miner Res (2003) 0.90
Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer. Mol Cancer Ther (2009) 0.90
Effects of the combination with alpha-tricalcium phosphate and simvastatin on bone regeneration. Clin Oral Implants Res (2009) 0.89
Disruption of NF-κB1 prevents bone loss caused by mechanical unloading. J Bone Miner Res (2013) 0.89
Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo. Int J Cancer (2012) 0.89
Histological and histomorphometrical comparative study of the degradation and osteoconductive characteristics of alpha- and beta-tricalcium phosphate in block grafts. J Biomed Mater Res B Appl Biomater (2007) 0.88
Increase in bone mineral density through oral administration of shark gelatin to ovariectomized rats. Nutrition (2005) 0.88
Local application of rhTGF-beta2 enhances peri-implant bone volume and bone-implant contact in a rat model. Bone (2005) 0.88
Antagonism between apoptotic (Bax/Bcl-2) and anti-apoptotic (IAP) signals in human osteoblastic cells under vector-averaged gravity condition. Ann N Y Acad Sci (2003) 0.87
LPS-induced inhibition of osteogenesis is TNF-alpha dependent in a murine tooth extraction model. J Bone Miner Res (2009) 0.87
Osteoclast formation and differentiation: an overview. J Med Dent Sci (2012) 0.87
A novel underuse model shows that inactivity but not ovariectomy determines the deteriorated material properties and geometry of cortical bone in the tibia of adult rats. J Bone Miner Metab (2010) 0.86
Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity. J Bone Miner Metab (2009) 0.86
Evaluation of the osteoconductivity of α-tricalcium phosphate, β-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect. J Biomed Mater Res A (2011) 0.86
Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. J Med Dent Sci (2003) 0.85
In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific oncolytic virotherapy. Ann Surg (2010) 0.85
Significant enhancement of ferromagnetism in Zn1-xCrxTe doped with iodine as an n-type dopant. Phys Rev Lett (2006) 0.85
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression. Eur J Cancer (2012) 0.85
A simple murine model for immobilization osteopenia. Clin Orthop Relat Res (2004) 0.85
A tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice. J Periodontal Res (2006) 0.85
Suppression of osteoblastic phenotypes and modulation of pro- and anti-apoptotic features in normal human osteoblastic cells under a vector-averaged gravity condition. J Med Dent Sci (2003) 0.84
Relevance of resonance frequency analysis to evaluate dental implant stability: simulation and histomorphometrical animal experiments. Clin Oral Implants Res (2007) 0.83
Local application of rhTGF-beta2 modulates dynamic gene expression in a rat implant model. Bone (2005) 0.83
Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture. J Bone Miner Res (2003) 0.83
Factors affecting accuracy of implant placement with mucosa-supported stereolithographic surgical guides in edentulous mandibles. Comput Biol Med (2013) 0.82
Peptide-based delivery to bone. Adv Drug Deliv Rev (2012) 0.82
Bone regeneration of rat tibial defect by zinc-tricalcium phosphate (Zn-TCP) synthesized from porous Foraminifera carbonate macrospheres. Mar Drugs (2013) 0.82
Magnitude and direction of mechanical stress at the osseointegrated interface of the microthread implant. J Periodontol (2010) 0.82
Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice. Mol Endocrinol (2012) 0.82
NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Arthritis Res Ther (2007) 0.82
Bovine dentine organic matrix down-regulates osteoclast activity. J Bone Miner Metab (2009) 0.82
Increased bone mass in adult prostacyclin-deficient mice. J Endocrinol (2009) 0.82
Antimicrobial photodynamic therapy suppresses dental plaque formation in healthy adults: a randomized controlled clinical trial. BMC Oral Health (2014) 0.82
Biodegradation process of alpha-TCP particles and new bone formation in a rabbit cranial defect model. J Biomed Mater Res B Appl Biomater (2006) 0.81
Implantation of green tea catechin α-tricalcium phosphate combination enhances bone repair in rat skull defects. J Biomed Mater Res B Appl Biomater (2011) 0.81
p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption. J Bone Miner Res (2013) 0.81
[Clinical study of risk management for dental implant treatment--changes of blood pressure and pulse rate during implant surgery under local anesthesia]. Kokubyo Gakkai Zasshi (2002) 0.81
Gene expression of bone matrix proteins in a calcified tissue appeared in subcutaneously transplanted rat dental pulp. J Med Dent Sci (2002) 0.81
Bone augmentation ability of autogenous bone graft particles with different sizes: a histological and micro-computed tomography study. Clin Oral Implants Res (2009) 0.81
Hypergravity stimulates osteoblast phenotype expression: a therapeutic hint for disuse bone atrophy. Ann N Y Acad Sci (2004) 0.80
Evaluation of 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer-coated dressing on surgical wounds. J Med Dent Sci (2005) 0.80
Inhibition of BMP2-induced bone formation by the p65 subunit of NF-κB via an interaction with Smad4. Mol Endocrinol (2014) 0.80
Induced osteogenesis using a new periosteal distractor. J Oral Maxillofac Surg (2012) 0.80
Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2. Biochem Pharmacol (2003) 0.80
Canine oral mucosal fibroblasts differentiate into osteoblastic cells in response to BMP-2. Anat Rec (Hoboken) (2012) 0.80
Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in vivo. J Bone Miner Metab (2008) 0.80
Three-dimensional characterization of osteoclast bone-resorbing activity in the resorption lacunae. J Med Dent Sci (2009) 0.80
Differentiation of bone marrow stromal cells into osteoblasts in a self-assembling peptide hydrogel: in vitro and in vivo studies. J Biomater Appl (2010) 0.79